PET Imaging Targeting Granzyme B Predicts Immunotherapy Efficacy in Diffuse Large B-cell Lymphoma
Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY
This study aims to investigate the predictive value of PET imaging targeting granzyme B on the outcome of patients with diffuse large B lymphoma receiving immunotherapy.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Pathologic diagnosis of DLBCL
• Patient's general condition is good and survival is expected to be greater than six months
• Signed and dated informed consent form
Locations
Other Locations
China
Ruijin Hospital Affiliated to Shanghai Jiao Tong University Medical School
RECRUITING
Shanghai
Contact Information
Primary
Xinyi Zhu
zxy16zz@163.com
19121913585
Time Frame
Start Date: 2024-07-23
Estimated Completion Date: 2029-07-23
Participants
Target number of participants: 150
Treatments
patients diagnosed with DLBCL who will receive immunotherapy (CAR-T, glofitamab, iR2)
Related Therapeutic Areas
Sponsors
Leads: Ruijin Hospital